Top Markets
#1 Siren Siren +33.90%
#2 Wiki Cat Wiki Cat +25.38%
#3 TRIA TRIA +20.37%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +15.56%
#7 Bitway Bitway +15.11%
#8 Nockchain Nockchain +14.64%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.63%
#10 KUB Coin KUB Coin +14.59%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Classificação em ações #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Preço da ação
$0.089
Última sincronização: 2026-08-17
Valor de mercado
$15.36M
Variação (1 dia)
50.59%
Variação (1 ano)
111.85%
País
US
Negociar Inhibitor Therapeutics, Inc. (INTI)

Categoria

Healthcare
Histórico de preços das ações de Inhibitor Therapeutics, Inc. (INTI)
Preço de fecho mais alto: $0.08 em 2026-08-01

Preço de fecho mais baixo: $13.64 em 2003-09-01
Histórico de preços das ações da Inhibitor Therapeutics, Inc. de 2003 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 36.71%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 50.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE